However, on average, patients who developed LR received fewer cycles of high-dose methotrexate (6.7 cycles) than those who did not (9.1 cycles), though this did not reach statistical significance ( p = 0.092).
← all excerpts
Chondroblastic Subtype Is Associated with Higher Rates of Local Recurrence in Skeletal Osteosarcoma.
1
0.0920
0.0920